Pular para o conteúdo principal
Ranking Invest

PRAX - Praxis Precision Medicines, Inc.

Segmento: HealthcarePraxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of major depressive disorder and perimenopausal depression; and PRAX-944, a selective small molecule inhibitor of T-type calcium channels, which is in Phase IIa clinical trial for the treatment of essential tremor. The company is also developing PRAX-562, a persistent sodium current blocker that is in Phase I clinical trial to treat severe pediatric epilepsy and adult cephalgia; PRAX-222, an antisense oligonucleotide (ASO) for patients with gain-of-function (GOF) SCN2A epilepsy; and KCNT1 program for the treatment of KCNT1 GOF epilepsy. It has a cooperation and license agreement with RogCon Inc.; a license agreement with Purdue Neuroscience Company; a research collaboration, option, and license agreement with Ionis Pharmaceuticals, Inc.; and collaboration with The Florey Institute to develop three novel ASOs. The company was incorporated in 2015 and is based in Boston, Massachusetts.

Análise Ranking Invest

Valor de Mercado
$ 7.97 Bi
IVR
0.07Índice proprietário de comparação relativa: 0,07.
IVR2
-0.10Leitura proprietária complementar: -10%.
MLL
-0.10Leitura proprietária complementar: -10%.
Último Balanço Atualizado: 2T2026

O Ranking Invest utiliza metodologia proprietária baseada em dados financeiros públicos; fórmulas e valores intermediários são confidenciais.

Dados da Empresa

Patrimônio Líquido

$ 1.34 Bi

Dívida Líquida

-$ 474.76 Mi

L4T

-$ 339.13 Mi

Indicadores Básicos

ROE

-25.29%

Índices de Previsibilidade

Receita Líquida

G0.84

Lucro

B0.21

Margem

D1.01

Índices de Tendência

Receita Líquida

E-6.52

Lucro

G-10.32

Margem

C3.04

Índices de Endividamento

DIV/PAT

-0.35

DIV/L4T

1.40

Dívidas
Cotação
Gráfico Lucro/Receita Líquida X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.